All treatments
Treatment
Upadacitinib, Upadacitinib clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Subjects with Crohn's Disease
This study looks at how safe and effective a drug called Upadacitinib is over a long time for people with Crohn's disease. It checks if the drug helps people feel better and if they stay better, as well as any side effects.
For: Crohn's Disease (CD)Slovakia · Netherlands · France - Ongoing, recruitingPhase III and phase IV (Integrated)
A Phase 3b/4 Randomized, Blinded, Treat-to-Target and Dose-Flexibility Study of Upadacitinib in Adult Subjects with Moderate to Severe Atopic Dermatitis (Flex-Up)
This study looks at a medicine called Upadacitinib for adults with moderate to severe eczema. It wants to see how well it clears up skin symptoms and improves quality of life. The study compares different ways of giving the medicine.
For: Dermatitis atopicNetherlands · Spain · Portugal